01

About This Document

This document defines the strategic foundation of the Alveon brand. It is the central reference for anyone working with or representing Alveon: the internal team, agency partners, and investor communications.

It captures who we are, what we stand for, how we speak, and where we are going. Every creative brief, campaign concept, and brand touchpoint should be measured against the principles outlined here.

02

Brand Foundation

Purpose

Football boots are the most critical piece of equipment a player wears. Yet even at the highest professional level, they are not truly custom. Players receive superficial personalization: colors, initials, minor width adjustments. The boot itself remains a mass-produced product, built around statistical averages rather than individual anatomy.

Alveon exists to change this. We are building the world's first football boots that are genuinely made to measure: designed from a player's individual 3D foot scan, informed by biomechanical data, and manufactured entirely with 3D technologies. Not as a luxury novelty, but as an evidence-based approach to injury prevention, career protection, and performance optimization.

Mission

To eliminate the gap between a player's individual needs and the equipment they depend on. Through science, data, and advanced manufacturing.

Vision

A world where every professional football player wears boots built specifically for them. Reducing injuries, extending careers, and unlocking the performance potential that mass production leaves on the table.

Brand Values

Scientific Rigor
We don't guess. Every product decision is grounded in biomechanical research, clinical data, and material science. Our partnership with leading universities and research institutions is not marketing. It is our methodology.
Individual First
Every foot is different. Every movement pattern is unique. We start with the individual player and work outward, never the other way around. Mass customization is not customization.
Understated Excellence
We let the work speak. Our credibility comes from results, not from noise. We build quietly, prove thoroughly, and communicate with precision.
Radical Honesty
We are transparent about what we know and what we don't know yet. We openly acknowledge the complexity of what we're building. This honesty is a strength, not a weakness.
Long-Term Thinking
We are not optimizing for hype cycles. We are building technology and evidence that compound over time. The best product in 2028 is the foundation for a better one in 2030.
03

Origin Story

The Alveon story doesn't start with a eureka moment. It starts with a question that kept coming back.

Co-founder Jurgen was never a great football player. By his own account, his teammates were not particularly sad when he quit. But years later, through work in the sports industry, he gained access to a world he hadn't seen before: the daily reality of professional players. The pressure, the details, the ecosystem around performance.

In conversations with players, one pattern emerged consistently: they don't really have custom boots. Even at the top level, what passes for customization is surprisingly rudimentary. Limited options, long lead times, little real adaptation to the individual foot.

Around the same time, Jurgen met Lennard, co-founder of Zellerfeld, a company building 3D-printed footwear. Over coffee, they kept returning to the same question: Why are football boots not fully custom? Built on real data. Adjusted to individual anatomy, movement patterns, and injury history.

They discussed the idea for nearly two years. Not because they lacked enthusiasm, but because they took the question seriously. Who were they to say what the perfect boot should look like? Which parameters actually matter? And how do you prove scientifically that your approach is better than what exists?

That rigor led to the decision to build Alveon not as a product company that also does some research, but as a company where science leads product development. In early 2026, a joint research initiative was launched with three of Germany's leading institutions: the Deutsche Sporthochschule Koln for biomechanics, UKE Hamburg for clinical validation, and Fraunhofer IAPT for materials and manufacturing research.

The founding principle remains: the boot should be as individual as the player wearing it. Everything else follows from there.

Why This Story Matters for the Brand

The origin story is strategically important because it communicates several brand truths simultaneously: intellectual honesty (we started by admitting what we didn't know), scientific credibility (we built a research consortium before building a product), and authentic motivation (born from a real observation, not from a market gap analysis). It positions the founders as thoughtful rather than reckless. That matters for a company asking players to trust its product with their careers.

04

Market Context & Positioning

The Current Landscape

The global football boot market is dominated by Nike, Adidas, Puma, and New Balance. These brands invest heavily in material innovation, athlete endorsements, and consumer marketing. Their products are excellent mass-market solutions, developed with significant R&D budgets and global distribution infrastructure.

However, their business model is fundamentally built on scale: produce millions of identical units across a limited range of sizes and widths. Even "custom" offerings from major brands are typically limited to cosmetic personalization (colors, nameplates) and minor fit adjustments within predefined molds.

For the vast majority of professional players, boots are selected from existing product lines and modified post-purchase through insoles, stretching, or cutting. The boot adapts marginally to the foot; the foot adapts significantly to the boot.

The Gap We Address

Alveon operates in a category that doesn't properly exist yet: fully individualized professional football footwear, built from individual biomechanical data and manufactured through digital fabrication.

We are not competing with Nike or Adidas for shelf space. We are not a consumer brand. We are a technology company that creates the capability to produce boots that major brands currently cannot offer. Their manufacturing infrastructure is designed for volume, not for individualization.

Competitive Differentiation

Research-Led Development
Our product roadmap is driven by a two-year clinical study involving three leading research institutions. We don't just claim our boots are better. We are building the scientific evidence to prove it.
Full Digital Pipeline
From 3D foot scan to finished boot, the entire workflow is digital. Scan, biomechanical analysis, parametric design, 3D knitting, 3D-printed soles. No manual lasts, no traditional molds.
Mono-Material Architecture
Our TPU-based mono-material approach enables thermal bonding without adhesives. This is both a performance advantage (lighter, more consistent) and a sustainability advantage.
B2B Technology Model
Alveon's primary commercial model is not selling individual boots to consumers. It is licensing complete scan-to-boot installations (Performance Centers) to clubs, federations, and brands.

Positioning Statement

Alveon is the technology company building truly individualized football boots. Where existing brands optimize for millions, we engineer for one. Combining 3D scanning, biomechanical research, and digital manufacturing to create footwear that fits the player, not the average.
05

Target Audiences

Alveon communicates with multiple audiences, each with distinct motivations and decision criteria. The messaging framework (Section 07) provides tailored language for each. Below are the primary audience segments, ordered by strategic priority.

Professional Football Players

First-team players at top-tier clubs (top 5 European leagues, international teams). These athletes depend on their boots for performance and injury prevention, yet have limited control over what they wear.

Pain Points

Boots that don't fit properly cause blisters, discomfort, and contribute to foot and ankle injuries. Customization from existing sponsors is slow and cosmetic. Players often cut, stretch, or modify boots themselves. Boot changes during injury recovery are disruptive.

Alveon Delivers

Boots built from their individual 3D scan and biomechanical profile. Clinically validated injury reduction. Rapid iteration when needs change. A product that treats their feet as the high-value assets they are.

Club Medical & Performance Staff

Head of medical, physiotherapists, performance directors, and equipment managers at professional clubs. They are responsible for player availability and are often the first to recognize boot-related issues.

Pain Points

Limited influence over boot choices (driven by sponsorship deals). No objective data on boot-injury correlations for individual players. Reactive approach: treating boot-related injuries rather than preventing them.

Alveon Delivers

Data-driven boot fitting integrated into player health management. Evidence-based injury prevention. A Performance Center on-site that puts footwear into the medical staff's toolkit.

Sports Brands & Licensees

Established footwear and sportswear companies exploring individualization capabilities. These are potential partners for Performance Center installations and technology licensing.

Pain Points

Existing manufacturing infrastructure cannot produce truly individualized products at any scale. Consumer demand for personalization is growing. Innovation pressure from competitors and from adjacent categories (running, basketball).

Alveon Delivers

A turnkey technology solution. The Performance Center extends their brand into genuine customization without rebuilding their manufacturing from scratch. Proven technology stack with clinical evidence.

Investors

Seed and Series A investors, particularly those focused on deep tech, sports tech, and advanced manufacturing. Seeking ventures with defensible technology moats and clear commercial models.

Pain Points

Sports tech is often marketing-heavy and technology-light. Differentiation claims are difficult to validate. Market timing and go-to-market clarity are critical.

Alveon Delivers

A science-led company with a research consortium, a digital manufacturing pipeline, a clear B2B model (Performance Centers), and a strategic timeline anchored to EURO 2028.

06

Brand Personality & Tone of Voice

Brand Personality

If Alveon were a person, it would be the engineer-athlete: deeply technical, physically aware, quietly confident. Someone who earns trust through knowledge and consistency rather than charisma and volume. Think of the team doctor who played at a high level. They understand both the science and the stakes.

Confident, not arrogant
We know our technology is groundbreaking. We communicate this through evidence and clarity, never through hyperbole or comparison-based superiority claims.
Scientific, not academic
We are research-led but commercially minded. Our communication makes complexity accessible without dumbing it down. We use precise language, not jargon.
Modern, not trendy
Our aesthetic and tone reflect contemporary design thinking and advanced technology. We don't chase trends or adopt visual languages that will feel dated in two years.
Human, not clinical
Behind the technology are real players with real concerns. Our communication always connects back to the human impact. The career protected. The injury prevented.

Tone of Voice Principles

1. Lead with substance, not adjectives.

Every claim should be supportable. If we say something is "better," we should be able to explain how and why. If we can't yet, we say "we're working to prove it."

Do

"The Alveon boot is shaped from a 3D scan of the player's foot, capturing over 50,000 data points that inform the knitting pattern, sole geometry, and reinforcement zones."

Don't

"Our revolutionary, game-changing boots use cutting-edge AI-powered technology to deliver an unparalleled, best-in-class fit experience."

2. Be honest about the journey.

We are a young company doing something that hasn't been done before. Acknowledging complexity and uncertainty is a sign of credibility, not weakness.

Do

"We're two years into a clinical study designed to measure whether individualized boots reduce injury rates. Early indicators are promising. The full data will tell the story."

Don't

"Our scientifically proven technology eliminates injuries and guarantees peak performance."

3. Respect the audience's intelligence.

Whether speaking to a player, a medical director, or an investor: assume they are smart and don't need to be convinced through emotional manipulation. Give them information and let them draw conclusions.

Do

"The average top-league club loses 15% of its squad to injury at any given time. Boot fit is a modifiable factor. We believe it's an underexplored one."

Don't

"Imagine the heartbreak of a player sidelined because of the wrong boots! Don't let this happen to your athletes!"

4. Keep it concise.

Precision in language reflects precision in thinking. Short sentences. Clear structure. No filler.

Language Do's and Don'ts

Use Avoid
individualized, made-to-measure bespoke, luxury, exclusive
evidence-based, research-led revolutionary, game-changing, disruptive
digital manufacturing, 3D technologies cutting-edge, AI-powered (unless literally true)
injury prevention, career protection wellness, health-focused, orthopaedic
performance optimization supercharging, turbocharging, unlocking potential
we are building, we are proving we have solved, we have cracked
07

Messaging Framework

Core Narrative 30 seconds

Alveon builds the world's first truly individualized football boots. We combine 3D scanning, biomechanical research, and advanced digital manufacturing to create boots shaped around the player, not around an average. Our mission is to reduce injuries, protect careers, and set a new standard for what professional equipment can be.

Elevator Pitch 60 seconds

Professional football players depend on their boots more than any other piece of equipment. Yet even the best boots on the market are mass-produced. Designed for statistical averages, not for the individual foot. Alveon changes this. We've built a complete digital pipeline: from 3D foot scanning and biomechanical analysis to 3D-knitted uppers and 3D-printed soles. Every boot is manufactured to the player's exact anatomy and movement profile. Our approach is backed by a two-year clinical study with three leading German research institutions. We're targeting EURO 2028 as our first major showcase and commercialize through Performance Centers: turnkey installations at clubs and brands that bring our scan-to-boot technology on-site.

Key Messages by Audience

For Players

"Your boots should fit you. Not the other way around. Alveon boots are built from a scan of your foot, designed around how you move, and manufactured to your exact measurements. Better fit means fewer injuries, more comfort, and more time on the pitch."

For Medical & Performance Staff

"Alveon integrates footwear into player health management. Our 3D scanning and biomechanical analysis give you objective data on each player's foot. Our boots are designed to address individual risk factors. And our Performance Center brings this capability directly to your facility."

For Brands & Partners

"Alveon's Performance Center is a turnkey solution that brings genuine individualization to your brand. We provide the complete technology stack: scanning, analysis, manufacturing. All backed by clinical evidence. You provide the brand, the athletes, the market. Together, we create a capability your competitors cannot match."

For Investors

"Alveon is a deep-tech sports company building individualized football boots through a fully digital manufacturing pipeline. Our competitive moat combines proprietary scan-to-boot software, a research consortium with three German universities, and a B2B model based on Performance Center installations. We're targeting EURO 2028 as our market entry, with seed funding closing in Q1 2026 at a 10M post-money valuation."

08

Visual Identity Direction

The visual identity is not yet developed. This section provides strategic direction for agency partners tasked with creating it. The following principles should guide all visual development.

Design Principles

Global Brand Ambition
The visual identity should be conceived at the level of the world's leading sports and technology brands. This is not a startup aesthetic. It is the foundation for a global brand. Think long-term: the identity must work across boot design, digital platforms, physical spaces (Performance Centers), broadcast, and print.
Precision Over Decoration
Every visual element should feel intentional. Favor clean geometry, structured layouts, and purposeful use of space. Avoid ornamentation that doesn't serve communication.
Confidence Without Aggression
The visual language should communicate authority and ambition without the hyper-masculine, speed-obsessed visual codes that dominate football marketing. Alveon is not about aggression; it's about intelligence.
Technology Made Tangible
The brand operates at the intersection of advanced manufacturing and human anatomy. The visual identity should make this tension feel resolved. Digital and physical. Precise and organic. Engineered and human.
Not a Health Brand
Critical: Alveon must never look or feel like a medical, orthopaedic, or wellness brand. Our category is high-performance sports technology. The visual codes should reference precision engineering, advanced materials, and athletic excellence. Never clinics, therapy, or rehabilitation.

Visual Territory

The brand's visual world sits at the intersection of three reference points:

Performance Sports
The energy, ambition, and physical intensity of professional football. Dynamic movement, texture of pitch and material, the sensory reality of the game.
Precision Engineering
The language of advanced manufacturing: clean surfaces, parametric structures, toolpath aesthetics, material science imagery. Think automotive engineering or aerospace, not consumer electronics.
Scientific Visualization
Data made visual: biomechanical maps, pressure distributions, 3D scan renderings, structural analysis. Science as aesthetic, not as decoration.

Name & Trademark

The name "Alveon" is a registered EU trademark (publication March 2026). International filings (USA, UK, Switzerland) are in progress via the Madrid System within the six-month priority window. The name evokes "alveolar": cellular, structural, biological. It is not a literal reference. It should be treated as a coined word with no direct translation.

09

Strategic Roadmap

The brand strategy is designed to build credibility and visibility along a clear timeline, culminating in a major market moment at EURO 2028.

2026 Current Phase

Phase 1: Foundation

Establish the brand's strategic and visual foundation. This phase is primarily inward-facing: defining brand assets, developing the visual identity, and building the first prototypes that embody brand values. External communication is limited and selective. Founder-led storytelling on professional platforms. Targeted outreach to potential athlete partners. Initial presence at relevant industry events.

Key Milestones

Visual identity developed, first prototypes in athlete hands, seed funding secured, research consortium public-facing.

Brand Priority

Credibility through substance. Be known by the right people for the right reasons.

2027

Phase 2: Validation

Build external credibility through research results, athlete testimonials, and deeper industry presence. This phase bridges the gap between "promising startup" and "serious technology company." Communication expands to include PR, industry publications, conference presence, and curated athlete storytelling.

Key Milestones

Clinical study baseline data published, playable prototype v2, first Performance Center discussions with clubs/brands.

Brand Priority

Evidence builds reputation. Transition from "we're building something" to "here's what it does."

2028 EURO 2028

Phase 3: Launch

EURO 2028 is the launch moment. The goal is to have Alveon boots visible on the pitch. Even on one player. That moment announces the brand to a global audience. Simultaneously, the first Performance Center becomes operational, demonstrating commercial viability.

Key Milestones

Player wearing Alveon at EURO 2028, first Performance Center installed, launch campaign.

Brand Priority

From proof of concept to proof of market. Global visibility through a single, focused moment.

Long-Term Vision

Beyond EURO 2028, the brand evolves from a single-product company into the defining technology platform for individualized sports footwear. Performance Centers become the primary revenue driver, installed at clubs, national federations, and brand facilities globally. The 2030 World Cup represents the next major milestone. Expansion into adjacent sports (running, basketball, rugby) becomes possible once the core football technology is proven.

10

Appendix: Key Facts

Quick reference for anyone working with the Alveon brand. These facts are current as of February 2026 and will be updated as the company develops.

Company

Legal EntityAlveon GmbH, Hamburg (in formation)
Founded2026
FoundersJürgen Alker and Lennard Stoever
HeadquartersHamburg, Germany
StagePre-Seed / Seed

Research Consortium

Deutsche Sporthochschule KolnBiomechanical analysis and movement science (Prof. Dr. Wolfgang Potthast)
UKE HamburgClinical validation and injury study (Prof. Dr. med. Gotz Welsch)
Fraunhofer IAPTMaterials science and additive manufacturing (Prof. Dr.-Ing. Ingomar Kelbassa)
Study DesignTwo-year clinical study: Year 1 baseline (conventional boots), Year 2 intervention (individualized prototypes)